Cargando…
Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049565/ https://www.ncbi.nlm.nih.gov/pubmed/21224852 http://dx.doi.org/10.1038/sj.bjc.6606068 |